HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Spitz, M Articles by Barbosa, E R Search for Related Content PubMed PubMed Citation Articles by Spitz, M Articles by Barbosa, E R

Parkinsonism in type 1 Gaucher’s disease

¹ Movement Disorders Unit, Neurology Department, University of São Paulo Medical School, São Paulo, Brazil
² Molecular Genetics Laboratory, Biology Institute, University of São Paulo
³ Haematology Department, University of São Paulo Medical School
⁴ Movement Disorders Unit, Neurology Department, University of São Paulo Medical School

Correspondence to:
Correspondence to:
Dr Mariana Spitz
marianaspitz@gmail.com

Keywords: Gaucher’s disease; parkinsonism

The first 150 words of the full text of this article appear below.

Gaucher’s disease (GD) is the most common hereditary lysosomal storage disorder, with a prevalence of 1:57 000 in the general population.¹ The disease results from mutations in the glucocerebrosidase (GBA) gene, localised in chromosome 1 (the most frequent mutation is N370S) and has an autosomal recessive pattern of transmission. As a result of such mutations, there is decreased activity of the enzyme and subsequent glucocerebroside accumulation in cells of the macrophage-monocyte system. This process may lead to hepatosplenomegaly, bone disease, and pancytopenia.

GD is classically divided into three types, according to the presence of neurological symptoms and the dynamics of the developing clinical picture.² Type 1 GD is the most common, affects mainly Ashkenazi Jews, and until recently was considered non-neuronopathic. It may present at any age and its course and presentation are variable. Many type 1 GD patients remain virtually asymptomatic, being diagnosed during evaluation for a non-related disorder . . . [Full text of this article]